Balancing benefit against risk in the choice of therapy for coronary artery disease: Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery

Minerva Cardioangiologica

Volumn 51, Issue 5, 2003, Pages 585-597

  Morrison, D A ^a   Sacks, J ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b Vet Aff Coop Studs Prog C C   (United States)

Author keywords

Coronary artery bypass graft surgery; Coronary artery disease; Myocardial infarction; Percutancous coronary intervention; Randomized clinical trials

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DUTEPLASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY RISK; DRUG INDICATION; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; OUTCOMES RESEARCH; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK BENEFIT ANALYSIS; STROKE; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; HUMANS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT;

EID: 0346789110     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM et al. ACC/AHA Task Force Report. Guidelines for the Management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-428.
2. Ryan TJ, Antman EM, Brooks NH, Califf RM, Hillis LD, Hiratzka LF et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999;34:890-911.
3. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the management of patients with Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
4. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: summary article; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (Committee on the management of patients with Unstable Angina). J Am Coll Cardiol 2002;40:1366-74.
5. Guidelines and indications for coronary artery bypass graft surgery. A report of the American College of Cardiology/American Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1991;17:543-89.
6. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ et al. ACC/AHA guidelines for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 1999;34:1262-346.
7. Guidelines for Percutaneous Transluminal Coronary Angioplasty: A Report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 1993;22:2033-54
8. Smith SC jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ et al. ACC/AHA Guidelines for percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1993 Guidelines for Percutaneous Coronary Transluminal Angioplasty). J Am Coll Cardiol 2001;37:2239i-lxvi.
9. Morrison DA, Sacks J, Barbiere CC, Sethi G. PTCA comes to the bifurcations in the road: what the VA has to offer. J Am Coll Card 1997;29:1512-4.
10. Eleven year survival in the veterans administrations randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med 1984;311:1333-9.
11. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery study. N Engl J Med 1988;319:332-7.
12. Coronary artery surgery study (CASS): a randomized trial of coronary bypass surgery. Survival data. Circulation 1983;68:939-50.
13. Luchi RJ, Scott SM, Deupree RH. Comparison of medical and surgical treatment for unstable angina pectoris. Results of a Veterans Administration Cooperative Study. N Engl J Med 1987;316:977-84.
14. Scott SM, Luchi RJ, Deupree RH. Veterans administration cooperative study for treatment of patients with unstable angina. Results in patients with abnormal left ventricular function. Circulation 1988;78(3 Pt 2):113-21.
15. Parisi AF, Khuri S, Deupree RH, Sharma GVRK, Scott SM, Luchi RJ. Medical compared with surgical management of unstable angina 5 year mortality and morbidity in the veterans administration study. Circulation 1989;80:1176-89.
16. Unstable angina pectoris: National Cooperative Study Group to compare medical and surgical therapy I. Report of protocol and patient population. Am J Cardiol 1976;37:896-902.
17. Unstable angina pectoris: National Cooperative Study Group to compare surgical and medical therapy II. In-Hospital experience and initial follow-up results in patients with one, two, and three vessel disease. Am J Cardiol 1978;42:839-48.
18. Unstable angina pectoris: National Cooperative Study Group to compare surgical and medical therapy III. Results in patients with S-T segment elevation during pain. Am J Cardiol 1980;45:819-24.
19. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME Investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-6.
20. Coronary Angioplasty versus Medical Therapy for Angina: the second Randomized Intervention Treatment of Angina (RITA-2) Trial. RITA-2 trial Participants. Lancet 1997;350:461-8.
21. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastin versus Revascularization Treatment Investigators. N Engl J Med 1993;341:70-6.
22. Bourassa MG, Knatterud GL, Pepine CJ, Sopko G, Rogers WJ, Geller NL et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) Study. Improvement of cardiac ischemia at 1 year after PTCA and CABG. Circulation 1995;92(9 Suppl):111-7.
23. Cesar LA, Hueb WA. The MASS trials. In: Morrison DA, Sermys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p. 203-16.
24. Lembo NJ, King SBIII. Randomized trials of percutaneous transluminal coronary angioplasty, coronary artery bypass grafting surgery, or medical therapy in patients with coronary artery disease. Coron Art Dis 1990;1:449-54.
25. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet 1993;341:573-80.
26. CABR1 Trial Participants. First Year Results of CABR1 (Coronary Angioplasty vs Bypass Revascularization Investigation). Lancet 1995;346:1179-84.
27. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH et al. A randomized trial comparing coronary angioplasty with coronary, bypass surgery. N Engl J Med 1994;331:1044-50.
28. Hamm CW, Riemers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multi-vessel coronary, disease. N Engl J Med 1994;331:1037-43.
29. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MI, Palacios IF. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery, in multi-vessel disease (ERACI): in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993;22:1060-7.
30. BARI Investigators: Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation 1991;84 (Suppl V):1-27.
31. Frye RL, King SB III, Sopko G, Detre KM. A symposium: Multi-vessel PTCA versus CABG: Baseline Data from the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty Surgery Trial (EAST). Am J Cardiol 1995;75:1-59c.
32. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy, JW et al. Effect of coronary artery bypass graft Surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563-70.
33. Pocock SJ, Henderson RA, Rickards AF, Hampton JR, King SB III, Hamm CW et al. Meta-analysis of randomized trials comparing coronary angioplasty with bypass surgery. Lancet 1995;346:1184-9.
34. Sim I, Gupta M, McDonald K, Bourassa M, Hlatky MA. A meta-analysis of randomized trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty in multi-vessel coronary artery disease. Am J Cardiol 1995;76:1025-9.
35. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation 1994;89:1545-56.
36. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG et al for the Veterans affairs Non-Q-Wave Infarction Strategies in Hospital (VAN-QWISH) Trial Investigators. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive strategy as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.
37. Fragmin and First Revascularization during instability in Coronary Artery Disease Investigators: Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet 1999;3554:708-15.
38. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkisn N et al. for the TACTICS-Thrombolysis in Myocardial Infarction 18 investigators. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
39. Fox KAA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR et al. for the Randomized Intervention Trial of unstable Angina (RITA) Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Lancet 2002;360:743-51.
40. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials. Lancet 2003;361:13-20.
41. Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
42. Ribeiro EE, Silva LA, Carneiro R, D'Oliveira LG, Gasquez A, Amino JG et al. Randomized trial of direct coronary angioplasty intravenous streprokinase in acute myocardial infarction. J Am Coll Cardiol 1993;22:376-80.
43. Grinfeld L, Berrocal D, Belardi J et al. Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): a randomized trial in a community hospital in Argentina (abstract). J Am Coll Cardiol 1996;27(Suppl.):A222.
44. Zijlstra F, Beukema WP, van't Hof AW, Liem A, Reiffers S, Hoorntje JC et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997;29:908-12.
45. Akhras F, Abu Ousa A, Swann G et al. Primary coronary angioplasty or intravenous thrombolysis for patients with acute myocardial infarction? Acute and late follow-up results in a cardiac care unit. J Am Coll Cardiol 1997;29(Suppl.):A235-6.
46. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000;21:823-31.
47. De Boer MJ, Ottervanger JP, van't Hof AW, Hoorntje JC, Suryapranata H, Zijlstra F et al. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol 2002;39:1723-8.
48. Widimsky P. Prague-2 trial. Conference of the European Society of Cardiology, August 31-September 4, 2002. Berlin, Germany.
49. DeWood MA. Direct PTCA vs intravenous t-PA in acute myocardial infarction: results from a prospective randomized trial. Proceedings of the Thromoblysis and Interventional Therapy in Acute Myocardial Infarction Symposium VI. Washington DC. George Washington University 1990.
50. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1993;328:673-9.
51. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med 1993;328:685-91.
52. Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M et al. Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression: immediate and long-term results of a randomized study. J Am Coll Cardiol 1998;32:1687-94.
53. Garcia E, Elizaga J, Perez-Castellano N, Serrano JA, Soriano J, Abeytua M et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999;33:605-11.
54. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 1997;336:1621-8. Erratum in: N Engl J Med 1997;337:287.
55. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Engl J Med 1997;336:1621-8. Erratum in: N Engl J Med 1997;337:287.
56. Le May MR, Labinaz M, Davies RF, Marquis JF, Laramee LA, O'Brien ER et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001;37:985-91.
57. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY et al. Comparison of Angioplasty and Prehospital Thromboysis in Acute Myocardial Infarction study group. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002;360:825-9.
58. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus thrombolysis for occluded coronary arteries in patients with acute myocardial infarction Study Investigators. N Engl J Med 2000;343:385-91.
59. Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG et al. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart 1999;82:426-31.
60. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
61. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 2002;359:920-5.
62. Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51. Erratum in: JAMA 2002;287:3212.
63. Aversano T, Aversano LT, Passamani E, Knatterud GL, Terrin ML, Williams DO et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51. Erratum in: JAMA 2002;287:3212.
64. Grines CL, Westerhausen DR jr, Grines LL, Hanlon JT, Logemann TL, Niemela M et al. A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol 2002;39:1713-9.
65. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999;341:625-34.
66. Weaver WD, Simes J, Betrieu A, Grines CL, Zijestra F, Garcia E et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review. JAMA 1997;278:2093-8.
67. Every NR, Maynard C, Cochran RP, Martin J, Weaver WD, for the Myocardial Infarction Triage and Intervention Investigators: Characteristics, management, and outcome of patients treated with acute myocardial infarction treated with bypass surgery. Circulation 1996;94(Suppl. II):II-81-6.
68. Stone GW, Brodie BR, Grines L, Boura J, O'Neill WW, and Grines CL for the Primary Angioplasty in Myocardial Infarction Trial-2 (PAMI-2) Investigators. Role of cardiac surgery in the hospital phase of management of patients treated with primary angioplasty for acute myocardial infarction. Am J Cardiol 2000;85:1292-6.
69. Rodriguez A, Bernardi V, Navia J, Baldi J, Grinfeld L, Martinez J et al. Argentine randomized study: coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple-vessel disease (ERA-Cl II): 30-day and one-year follow-up results. J Am Coll Cardiol 2001;37:51-8.
70. Ryan TJ. Present-day PTCR versus CABG: a randomized comparison with a different focus and a new result. J Am Coll Cardiol 2001;37:59-62.
71. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP et al for the Arterial Revascularization Therapies Study Group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-24.
72. The ARTS (Arterial Revascularization Therapies Study): Background, goals and methods. Int J Cardiovasc Intervent 1999;2:41-50.
73. SOS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet 2002;360:965-70.
74. Morrison DA, Sethi G, Sacks J, Grover F, Sedlis S, Esposito R et al. A multi-center, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. Control Clin Trials 1999;20:601-19.
75. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. J Am Coll Cardiol 2001;38:143-9.
76. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. Percutaneous coronary intervention versus bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME-Multicenter Registry: comparison with the randomized clinical trail. J Am Coll Cardiol 2002;39:266-73.
77. Morrison DA, Sethi G, Sacks J, Henderson W, Grover F, Sedlis S et al. for the Investigators of the Department of Veterans Affairs Cooperative Study No. 385, the Angina With Extremely Serious Operative Mortality, Evaluation (AWESOME). Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol 2002;40:1951-4.
78. Sedlis S, Morrison DA, Lorin J, Esposito R, Sethi G, Sacks J et al. for the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass; outcome of diabetic patients in the AWESOME randomized trial and registry. J Am Coll Cardiol 2002;40:1555-66.
79. Monison DA, Sacks J, Henderson W, Sethi G. The AWESOME Trial. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.217-34.
80. Hannan EL, Raez MJ, McCallister BD, Ryan TJ, Arani DT, Isom OW et al. A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1999;33:63-72.
81. Jones RH, Kesler K, Phillips HR 3rd, Mark DB, Smith PK, Nelson CL et al. long-term survival benefits of coronary, artery bypass grafting and percutaneous transluminal angioplasty in patiens with coronary artery disease. J Thorac Cardiovasc Surg 1996;111:1013-25.
82. Jones RH, Hannan EL, Hammermeister KE, Delong ER, O'Connor GT, Luepker RV et al. Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. J Am Coll Cardiol 1996;28:1478-87.
83. World Health Organization. Tobacco of Health? First Global Status Report. Geneva, Switzerland: World Health Organization, 1996.
84. Fuster V. Epidemic of cardiovascular disease and stroke; the three main challenges. Circulation 1999;99:1132-7.
85. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part 1: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001;104:2746-55.
86. Yusuf S, Reddy S, Ounpuu S, Anand S, Global burden of cardiovascular diseases. Part II: Variations in cardiovascular diseases by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104:2855-64.
87. Reddy KS, Yusuf S. Emerging epidemic of cardiovascular diseases in developing countries. Circulation 1998;97:596-601.
88. Bonow RO, Smaha LA, Smith SC, Mensah GA, Lenfant C. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 2002;106:1602-5.
89. Foot DK, Lewis RP, Pearson TA, Beller GA. Demographics and cardiology, 1950-2050. J Am Coll Card 2000;35:66B-80B.
90. Morrison DA, Thompson SP. Statins and other Lipid-lowering Agents. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.43-60.
91. Thai HM, Morrison DA. Angiotensin-converting Enzyme Inhibitors. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.61-72.
92. Lewis HD jr. Antiplatelet therapy. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.85-93.
93. Morrison DA, Sacks J. What constitutes medically refractory in the new millennium? In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz; 2002.p.11-24.
94. Grines CL. Fellows lecture on primary PCI on TCT.MD.com.
95. Lytle BW. Re-operative revascularization. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.265-82.
96. Park Seung-Jung: Elective stenting of left main coronary artery disease. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.265-82.
97. DeGeare VS, Grines CL. Coronary interventions in acute myocardial infarction. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.283-310.
98. Stauffer J-CE, Urban P. Acute myocardial infarction: SMASH perspective. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.311-26.
99. Mukherjee D, Bates ER, Hochman JS. Cardiogenic shock: SHOCK trial perspective. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.327-36.
100. Morrison DA, Sacks J. Cardiogenic shock: a VA perspective. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.337-46.
101. Mehta H, Meier B. Chronic occlusions. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.347-63.
102. Weiman D, Ramanathan K, Morrison DA. Chronic pulmonary disease. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.363-72.
103. Morrison DA, Veerakul G, Sastravaha K. Cerebrovascular and peripheral vascular comorbidity In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.373-86.
104. Bini EJ, Lascarides CE. Liver disease. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.387-414.
105. Pett SB jr: Renal function and high-risk coronary artery procedures. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz. 2002.p.415-24.
106. Sedlis SP, Lorin JD. High-risk coronary intervention in diabetic patients. In: Morrison DA, Serruys PW, editors. High-risk cardiac revascularization and clinical trials. London: Martin Dunitz, 2002.p.425-52.